A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 696 participants.
Also called NCT02414841
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 696 participants
- Sponsor
- Registry
-
NCT02414841
-
- Other papers using this trial's data
- PATENCY-2 trial of vonapanitase to promote radiocephalic fistula use for hemodialysis and secondary patency
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT02414841. Randomized; quadruple masking; primary purpose treatment. Start 2015-08 (actual); primary completion 2018-02 (actual). Results posted on 2019-08-13.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
- Condition
- Chronic Kidney Disease
- Intervention (Drug)
- Vonapanitase
- Intervention (Drug)
- Placebo
- Lead sponsor
- Proteon Therapeutics
Record details
- Record id
cardio:ct-nct02414841- Content hash
ebc89396b72641fe2b98efcc6b3cebea6113ff02827bd6471c8c05eaabec48cd